Carol Schafer, VP Finance - Communications at Lexicon Pharmaceuticals, holds 1.00K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 59.66K shares in Aceragen (Ticker: ACGN), holds ― shares in Five Prime Therapeutics (Ticker: FPRX). Most recently, Carol Schafer ― shares of Lexicon Pharmaceuticals on ― for an estimated value of ―.